Compared to the control cells (AG09390 and AG15007), an increase of 35–120 fold in the p11 mRNA levels was observed in all three human B-cell precursor leukemia cell lines established from ALL patients at first relapse (Fig 1B). Here, S100A10 is linked to leukemia.